The Netherlands Cancer Institute (NKI) is offering three fully funded PhD positions within the HER-CARE Doctoral Network, focusing on hereditary and early-onset breast cancer epidemiology. This international program aims to advance research on genetic, immunologic, and clinical risk factors for breast cancer, integrating data-driven approaches and clinical translation. Successful candidates will join a collaborative network of academic and industrial partners, participate in two secondments (one academic and one non-academic), and benefit from a dynamic research environment with access to state-of-the-art core facilities, network-wide training, and conference opportunities. Research projects include: (1) identifying risk and protective factors for contralateral breast cancer, (2) developing predictive models and online tools for shared decision-making in risk management, and (3) characterizing genomic signatures of early-onset breast cancer. The program emphasizes interdisciplinary collaboration, innovative statistical analysis, and integration of large-scale genomic, histological, and immunological data. Applicants must hold an MSc in epidemiology, biostatistics, bioinformatics, computational biology, or a related field such as public health, population genetics, or data science. Prior experience in cancer epidemiology is preferred. Candidates must demonstrate strong academic English skills, a problem-solving mindset, interdisciplinary curiosity, and excellent communication abilities for international teamwork. Eligibility requires that candidates have not resided or been mainly active in the Netherlands for more than 12 months in the 36 months prior to recruitment, must not already possess a PhD, and must hold a Master's degree before the program starts or by September 2026. Funding includes a four-year contract, a gross monthly salary between €3,665 and €4,450, holiday and personal life budget hours, annual holiday pay, end-of-year bonus, travel allowance, free parking, and discounts on public transport. The NKI provides a vibrant, multidisciplinary research environment with opportunities for professional development and collaboration across disciplines. To apply, candidates should submit a motivation letter, CV with MSc grades and publications, and contact details of two references as a single document via the application link. The deadline for applications is December 31, 2025. Interviews will be held in January and February 2026. For questions, contact [email protected].

The Netherlands Cancer Institute in Amsterdam is offering three fully funded PhD positions in the field of hereditary and early-onset breast cancer epidemiology as part of the HER-CARE Marie Skłodowska-Curie Doctoral Network. This international program brings together 9 academic and 3 industry partners across Europe, providing a unique multidisciplinary training environment for doctoral candidates. The positions are based in the Marjanka Schmidt Group and focus on three main research areas: risk and protective factors for breast cancer development, risk modelling and online tools for shared decision making, and genomic signatures of early-onset tumours. PhD candidates will conduct innovative research using large-scale datasets to improve breast cancer care, participate in international research visits and secondments, and receive comprehensive training in epidemiology, biostatistics, computational biology, and genomics. The HER-CARE network aims to advance personalized prevention and clinical management strategies for breast cancer, with projects involving the development of predictive models, integration of genomic and clinical data, and collaboration with leading institutions such as the University of Oxford and the Cambridge Centre for Cancer Genetic Epidemiology. Applicants must have a MSc degree in a relevant discipline (epidemiology, biostatistics, bioinformatics, computational biology, public health, data science, or population genetics) and meet the Marie Skłodowska-Curie mobility and degree requirements. The positions offer a competitive salary, generous benefits, and a dynamic international research environment. Applications are open until December 31, 2025. For more information, visit the HER-CARE website or contact [email protected].

The Netherlands Cancer Institute (NKI) is offering three fully funded PhD positions within the HER-CARE Doctoral Network, focusing on hereditary and early-onset breast cancer epidemiology. These positions provide an opportunity to contribute to innovative, interdisciplinary research on genetic, immunologic, and clinical risk factors for breast cancer. The HER-CARE network is a Marie Skłodowska-Curie Actions-Doctoral network, bringing together leading academic and industrial partners to train a new generation of researchers in breast cancer research. PhD candidates will work on projects such as identifying risk and protective factors for second breast cancers, developing predictive models and online tools for risk management, and characterizing genomic signatures of early-onset tumors. The research involves advanced statistical analyses, integration of large-scale genomic, histological, and immunological data, and collaboration with international partners through academic and non-academic secondments. Applicants must hold an MSc degree in epidemiology, biostatistics, bioinformatics, computational biology, or related fields such as public health, population genetics, or data science. Prior experience in cancer epidemiology is advantageous. Candidates must be fluent in academic English, possess strong problem-solving and communication skills, and be motivated to work in an interdisciplinary, international team. Eligibility criteria include not having resided or been mainly active in the Netherlands for more than 12 months in the 36 months prior to recruitment, not holding a PhD degree, and having a Master’s degree before the program start or by September 2026. The positions are fully funded for four years, with a competitive salary and benefits including holiday pay, travel allowance, free parking, and access to core research facilities. The dynamic research environment at NKI offers opportunities for professional development, collaboration, and participation in network-wide training events and conferences. Candidates will complete two secondments with academic and non-academic partners, broadening their research experience and professional network. To apply, candidates should submit a motivation letter, CV with MSc grades and publications, and contact details of two references as a single document. If the MSc certificate is not yet obtained, applicants should explain what remains to be completed and provide the expected graduation date. Applications are open until December 31, 2025, with interviews scheduled in January and February 2026. For questions, contact [email protected]. This opportunity is ideal for candidates passionate about cancer research, epidemiology, genomics, and clinical translation, seeking to make a significant impact on breast cancer outcomes through interdisciplinary collaboration and advanced research.

The Netherlands Cancer Institute (NKI) is offering three fully funded PhD positions within the HER-CARE Doctoral Network, focusing on hereditary and early-onset breast cancer epidemiology. This opportunity is part of a Marie Skłodowska-Curie Actions-Doctoral network, which brings together leading academic and industrial partners to advance research in early-onset and hereditary breast cancer. The HER-CARE network aims to characterize risk factors, develop innovative risk stratification and screening approaches, and identify multi-modal markers to improve clinical outcomes and decision-making for breast cancer patients. PhD candidates will join a dynamic, international research environment, collaborating with scientists across disciplines and institutions. The projects include: (1) identifying risk and protective factors for second breast cancer subtypes, (2) developing risk models and online tools for shared decision-making in risk management, and (3) characterizing genomic signatures of early-onset tumours. Each project involves international academic and non-academic secondments, providing broad professional experience and network-wide training. Applicants should hold an MSc in epidemiology, biostatistics, bioinformatics, computational biology, or a related field such as public health, population genetics, or data science. Experience in cancer epidemiology is advantageous. Candidates must have strong academic English skills, a problem-solving attitude, interdisciplinary curiosity, and excellent communication skills for international collaboration. Eligibility for the Marie Skłodowska-Curie Doctoral Network requires that candidates must not have resided or been mainly active in the Netherlands for more than 12 months in the 36 months prior to recruitment, must not already possess a PhD degree, and must hold a Master’s degree (or equivalent) before the start of the programme or by September 2026 at the latest. The positions are fully funded for four years, with a gross monthly salary between €3,665 and €4,450, annual holiday pay, end-of-year bonus, travel allowance, and additional benefits. The NKI offers a cutting-edge research environment, access to core facilities, and opportunities for professional development. Interested candidates should apply online, submitting a motivation letter, CV with MSc grades and publications, and contact details of two references as a single document. The application deadline is December 31, 2025, with interviews scheduled in January and February 2026. For further information, visit the official vacancy page or contact [email protected]. This is an excellent opportunity to contribute to impactful cancer research and clinical care in a leading European cancer institute.